- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 19/10 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Patent holdings for IPC class A61P 19/10
Total number of patents in this class: 1855
10-year publication summary
|
63
|
38
|
91
|
140
|
121
|
105
|
111
|
116
|
94
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2703 |
34 |
| Daiichi Sankyo Company, Limited | 1848 |
24 |
| Novartis AG | 10975 |
21 |
| The Regents of the University of California | 19780 |
16 |
| Osaka University | 3350 |
16 |
| Radius Health, Inc. | 92 |
14 |
| Bristol-myers Squibb Company | 4897 |
13 |
| Merck Patent GmbH | 5829 |
12 |
| Chugai Seiyaku Kabushiki Kaisha | 1330 |
12 |
| Boehringer Ingelheim International GmbH | 4705 |
11 |
| Kyowa Hakko Kirin Co., Ltd. | 280 |
11 |
| Sanofi | 4000 |
11 |
| Bayer Schering Pharma AG | 405 |
10 |
| Amgen Inc. | 4012 |
10 |
| Entera Bio Ltd. | 43 |
10 |
| sanofi-aventis | 377 |
10 |
| Wisconsin Alumni Research Foundation | 3862 |
9 |
| Asahi Kasei Pharma Corporation | 137 |
9 |
| Astellas Pharma Inc. | 1082 |
9 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3112 |
9 |
| Other owners | 1584 |